Chiron Investment Management LLC Reduces Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Chiron Investment Management LLC lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 23.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 12,668 shares of the medical equipment provider's stock after selling 3,803 shares during the quarter. Intuitive Surgical accounts for approximately 2.2% of Chiron Investment Management LLC's investment portfolio, making the stock its 18th largest position. Chiron Investment Management LLC's holdings in Intuitive Surgical were worth $6,223,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in ISRG. Mirador Capital Partners LP boosted its holdings in shares of Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider's stock worth $1,732,000 after acquiring an additional 50 shares during the period. Consolidated Planning Corp lifted its position in Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider's stock valued at $3,979,000 after purchasing an additional 1,198 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of Intuitive Surgical by 617.1% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider's stock worth $39,622,000 after buying an additional 76,649 shares during the last quarter. Swiss National Bank lifted its position in Intuitive Surgical by 0.3% in the 3rd quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider's stock worth $517,209,000 after buying an additional 3,400 shares during the last quarter. Finally, ABLE Financial Group LLC purchased a new stake in Intuitive Surgical in the third quarter worth approximately $604,000. 83.64% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares of the company's stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 270 shares of the business's stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,755 shares of company stock worth $26,273,943 over the last three months. Insiders own 0.90% of the company's stock.

Intuitive Surgical Price Performance

Shares of ISRG traded up $5.48 on Wednesday, hitting $543.57. The company's stock had a trading volume of 393,901 shares, compared to its average volume of 1,439,442. The company has a 50 day moving average price of $518.23 and a 200 day moving average price of $476.59. The company has a market capitalization of $193.61 billion, a PE ratio of 87.40, a PEG ratio of 5.41 and a beta of 1.38. Intuitive Surgical, Inc. has a fifty-two week low of $314.38 and a fifty-two week high of $556.23.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on ISRG. Raymond James boosted their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an "outperform" rating in a research report on Monday, October 14th. Truist Financial raised their price target on Intuitive Surgical from $520.00 to $570.00 and gave the company a "buy" rating in a report on Monday, October 14th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a report on Friday, October 18th. Evercore ISI reissued a "cautious" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, BTIG Research lifted their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a research note on Tuesday, November 26th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $550.28.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.